Calcific aortic stenosis (AS) is the most prevalent heart valve disorder in developed
countries. It is characterized by progressive fibro-calcific remodelling and thickening of the …

Tricuspid regurgitation (TR) is classified according to different morphologic types based on
the underlying mechanisms: primary, secondary, and isolated TR. Primary TR is caused by …

Aims In patients with aortic stenosis (AS), risk stratification for aortic valve replacement
(AVR) relies mainly on valve-related factors, symptoms and co-morbidities. We sought to …

Valvular disease remains a major cause of cardiovascular morbidity and mortality
worldwide. 1 Over the past decade, catheter-based interventions in valvular disease have …

The adverse effects of severe tricuspid regurgitation (TR) on longterm outcomes has now
been reported in a number of natural history studies. 1, 2 Current treatment for TR is …

Abstract Background: The SCOUT (Percutaneous Tricuspid Valve Annuloplasty System for
Symptomatic Chronic Functional Tricuspid Regurgitation) trial is a prospective, single-arm …

Transcatheter aortic valve implantation (TAVI) has matured into a standard treatment option
for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of …

Background Tricuspid regurgitation (TR), if untreated, is associated with an adverse impact
on long‐term outcomes. In recent years, there has been an increasing enthusiasm about …

Functional or secondary tricuspid regurgitation (TR) is the most common cause of severe TR
in the Western world. The presence of functional TR, either isolated or in combination with …

Background In patients with significant functional tricuspid regurgitation, timely detection of
right ventricular (RV) dysfunction with conventional 2-dimensional echocardiography is …